Stamaril Injection

Stamaril injection contains active components as Yellow fever vaccine. It is a crucial immunization that protects against the yellow fever virus. Yellow fever is a viral disease transmitted to humans through the bite of infected mosquitoes, primarily the Aedes aegypti mosquito. The primary benefit of this vaccine is its ability to prevent the potentially life-threatening disease caused by the yellow fever virus. Vaccinated individuals are far less likely to contract yellow fever when exposed to the virus. When a significant portion of the population is immune to the virus, it reduces the overall risk of transmission, protecting vulnerable individuals who cannot receive the vaccine due to medical reasons. A single dose of this vaccine typically provides long-lasting immunity for many years, often for a lifetime. The vaccine helps reduce the burden on healthcare systems by preventing yellow fever cases. If an individual has previously experienced a severe allergic reaction (anaphylaxis) to any component of the Stamaril injection, such as eggs or gelatin, they should not receive the vaccine. People with weakened immune systems due to conditions like HIV/AIDS, certain cancers, or immunosuppressive medications (e.g., high-dose steroids, chemotherapy) should generally not receive this vaccine. Individuals with severe thymus disorders like DiGeorge syndrome should avoid the vaccine. If an individual has had their thymus gland removed, they are typically advised not to receive this vaccine. Older adults can receive the vaccine if they are in good health and meet the other eligibility criteria. People allergic to Sorbital should not take this medicine. This Stamaril injection is not recommended for infants under 6 months of age.